Sabra Cash from 2010 to 2025

SBRA Stock  USD 17.33  0.28  1.59%   
Sabra Healthcare's Cash is increasing over the years with very volatile fluctuation. Overall, Cash is expected to go to about 85.3 M this year. Cash is the total amount of money in the form of currency that Sabra Healthcare REIT has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2010-09-30
Previous Quarter
63 M
Current Value
60.5 M
Quarterly Volatility
94.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sabra Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sabra Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 121.5 M, Interest Expense of 86.1 M or Selling General Administrative of 31.2 M, as well as many indicators such as Price To Sales Ratio of 9.78, Dividend Yield of 0.0646 or PTB Ratio of 1.53. Sabra financial statements analysis is a perfect complement when working with Sabra Healthcare Valuation or Volatility modules.
  
Check out the analysis of Sabra Healthcare Correlation against competitors.

Latest Sabra Healthcare's Cash Growth Pattern

Below is the plot of the Cash of Sabra Healthcare REIT over the last few years. Cash refers to the most liquid asset of Sabra Healthcare REIT, which is listed under current asset account on Sabra Healthcare REIT balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Sabra Healthcare customers. The amounts must be unrestricted with restricted cash listed in a different Sabra Healthcare account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Sabra Healthcare's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sabra Healthcare's overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Very volatile
   Cash   
       Timeline  

Sabra Cash Regression Statistics

Arithmetic Mean78,007,250
Geometric Mean43,932,873
Coefficient Of Variation154.86
Mean Deviation60,235,157
Median50,230,000
Standard Deviation120,802,768
Sample Variance14593.3T
Range514.3M
R-Value0.07
Mean Square Error15552.9T
R-Squared0.01
Significance0.79
Slope1,846,344
Total Sum of Squares218899.6T

Sabra Cash History

202585.3 M
202460.5 M
202341.3 M
202249.3 M
2021112 M
202059.1 M
201939.1 M

Other Fundumenentals of Sabra Healthcare REIT

Sabra Healthcare Cash component correlations

About Sabra Healthcare Financial Statements

Sabra Healthcare stakeholders use historical fundamental indicators, such as Sabra Healthcare's Cash, to determine how well the company is positioned to perform in the future. Although Sabra Healthcare investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sabra Healthcare's assets and liabilities are reflected in the revenues and expenses on Sabra Healthcare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sabra Healthcare REIT. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash60.5 M85.3 M
Cash And Short Term Investments60.5 M85.3 M
Change In Cash19.6 M20.6 M
Free Cash Flow310.5 M181.2 M
Other Cashflows From Financing Activities-94 K-89.3 K
Other Non Cash Items5.2 MM
Total Cash From Operating Activities310.5 M224.1 M
Total Cash From Financing Activities-181.6 M-172.5 M
End Period Cash Flow66.3 M88.6 M
Begin Period Cash Flow46.7 M44.4 M
Total Cashflows From Investing Activities-248.7 M-261.1 M
Other Cashflows From Investing Activities-109 M-103.6 M
Cash And Cash Equivalents Changes-56 M-53.2 M
Cash Flows Other Operating-4.9 M-4.7 M
Free Cash Flow Yield 0.08  0.08 
Operating Cash Flow Per Share 1.33  1.28 
Free Cash Flow Per Share 1.33  0.74 
Cash Per Share 0.26  0.25 
Capex To Operating Cash Flow 0.11  0.10 
EV To Operating Cash Flow 18.51  29.88 
EV To Free Cash Flow 18.51  24.32 
Price To Operating Cash Flows Ratio 13.02  16.84 
Price To Free Cash Flows Ratio 13.02  14.52 
Cash Ratio 0.03  0.03 
Cash Conversion Cycle 68.38  71.80 
Operating Cash Flow Sales Ratio 0.44  0.59 
Free Cash Flow Operating Cash Flow Ratio 0.82  0.86 
Cash Flow Coverage Ratios 0.18  0.18 
Price Cash Flow Ratio 13.02  16.84 
Cash Flow To Debt Ratio 0.18  0.18 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:
Check out the analysis of Sabra Healthcare Correlation against competitors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.827
Dividend Share
1.2
Earnings Share
0.54
Revenue Per Share
3.009
Quarterly Revenue Growth
0.125
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.